Autonomix Medical, Inc.
AMIX
$1.30
-$0.07-5.11%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -6.93% | -28.34% | 109.58% | 257.65% | 587.20% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 34.60% | -6.05% | 124.37% | 216.07% | 267.73% |
| Operating Income | -34.60% | 6.05% | -124.37% | -216.07% | -267.73% |
| Income Before Tax | 40.99% | 12.88% | 53.53% | -212.02% | -723.14% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 40.99% | 12.88% | 53.53% | -212.02% | -723.14% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 40.99% | 12.88% | 53.53% | -212.02% | -723.14% |
| EBIT | -34.60% | 6.05% | -124.37% | -216.07% | -267.73% |
| EBITDA | -35.19% | 7.29% | -- | -- | -- |
| EPS Basic | 75.06% | 52.30% | 71.90% | -112.68% | -327.92% |
| Normalized Basic EPS | 75.06% | 52.30% | 71.90% | -112.68% | -327.92% |
| EPS Diluted | 75.05% | 52.30% | 71.90% | -112.68% | -327.92% |
| Normalized Diluted EPS | 75.06% | 52.30% | 71.90% | -112.68% | -327.92% |
| Average Basic Shares Outstanding | 136.55% | 82.63% | 65.38% | 46.71% | 92.34% |
| Average Diluted Shares Outstanding | 136.55% | 82.63% | 65.38% | 46.71% | 92.34% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |